To make wise investments, clinicians must accurately estimate costs and know what they mean.
A Q&A with Michael S. Kaminer, MD
One expert recounts his experience with EMRs and offers a potentially positive outlook on the future of their use in dermatology and medicine.
Michael Sherling, MD, MBA
The time for careful analysis is before signing on the line. Here are the features a contract should address to set the tone for long-term satisfaction.
Lawrence Geller, MS, MBA
With common sense and knowledge of the therapy being administered, the dermatologist can effectively and safely treat MF patients.
Lawrence A. Mark, MD, PhD
No doubt the dermatology pharmaceutical industry is undergoing a change. But what does it mean?
A few relatively easy steps can increase the likelihood that potential patients who “shop” your practice will eventually purchase products or services.
Tom Powell and Laurie Mercier
Data suggest psoriasis involves barrier damage; topical barrier repair may support clearance.
Joseph B. Bikowski, MD
New staging criteria for melanoma have eliminated the Clark level of invasion and incorporated mitotic rate and serum LDH as important indicators.
Jonathan Wolfe, MD
With data mounting, it is essential that dermatologists monitor all patients who may be at risk for comorbidities and provide referrals when indicated.
Jerry Bagel, MD
A new study shows that off-label use of an unexpected agent yields promising results in the repigmentation of hypopigmented scars.
Ted Pigeon, Senior Associate Editor
Topical growth factors, antioxidants, peptides, and retinoids may have synergistic effects. Success depends on selection of the right ingredients used in the proper manner to achieve results.
Hema Sundaram, MD
From pre-authorizations to calculating procedure costs, here is what you need to know about the current era of high-deductible, bare-bones insurance.
Joel Schlessinger, MD